Table 2:
Group (Number of samples) |
T1 (ms) Mean ± SD |
T2 (ms) Mean ± SD |
ADC (×10−3 mm2/s) Mean ± SD |
---|---|---|---|
Normal Peripheral Zone (n=82) | 2240±360 | 146±61 | 1.68±0.31 |
Prostate Cancer (n=63) | 1660±270 | 56±20 | 0.70±0.24 |
Prostatitis (n=15) | 1760±350 | 77±36 | 1.00±0.30 |
Biopsy-proven Benign Prostatic Tissue (n=26) | 1810±250 | 71±37 | 1.00±0.33 |
Low-grade cancer/Gleason score = 6 (n=10) | 1690±400 | 75±29 | 0.96±0.34 |
Clinically significant cancers/Gleason score≥7 (n=53) | 1650±240 | 52±16 | 0.65±0.18 |
Non-Cancers (Prostatitis + Benign Prostatic tissue) (n=41) | 1790±290 | 73 ±37 | 1.00±0.32 |